Pharmaceutical Safety Center · South & Southeast AsiaEvery Uzbekistan dataset, comparison, and AI workpaper we maintain — one entry point for the whole market.
Check the BRV-denominated registration, recognition, renewal, and amendment fees charged by the Center for Pharmaceutical Product Safety.
Check whether product features may trigger separate radio, electrical, metrology, radiation, import, or other Uzbekistan requirements.
Follow recent State Center for Expertise and Standardization under the pharmaceutical-sector authority policy, guidance, safety, and compliance updates.
Compare official and realistic MoH approval times by device class and pathway.
Describe your device and get a preliminary MoH risk class with official rule references.
24 of 25 research dimensions currently covered · 11 official sources · latest verification 2026-09-15
Center for Pharmaceutical Product Safety (MoH) registration fees in UZS · reviewed 2026-08-25
| Fee line | Amount | Provenance |
|---|---|---|
| Primary (preliminary) expertise of the application - Class I | UZS 3,296,000 (8 BRV) | Verified |
| Primary (preliminary) expertise of the application - Classes IIa, IIb, III | UZS 4,120,000 (10 BRV) | Verified |
| Specialised expertise and registration decision - Class I (non-sterile, non-measuring, non-invasive) | UZS 11,536,000 (28 BRV) | Verified |
| Specialised expertise - Class I sterile, measuring, or invasive | UZS 18,540,000 (45 BRV) | Verified |
Ministry of Health of the Republic of Uzbekistan (Pharmaceutical Safety Center) review clocks and planning ranges · 4-class (I, IIa, IIb, III) — EU-aligned classification
The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.
Structure company, product, model, approval, certificate, and evidence facts before starting Uzbekistan work.
Connect the Pharmaceutical Safety Center route, evidence, labels, local role, timing, and dependencies to a wider launch plan.
Compare an existing authorization and evidence set against Pharmaceutical Safety Center administrative, testing, labeling, and dossier needs.
Map a product or manufacturing change to Pharmaceutical Safety Center evidence, notification, timing, and implementation questions.
Assess a current Pharmaceutical Safety Center update against one product and turn it into an owner-ready action workpaper.
Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for Uzbekistan (Pharmaceutical Safety Center).
Bangladesh
Cambodia
India
Indonesia
Malaysia
Myanmar
Pakistan
Philippines
Singapore
Sri Lanka
Thailand
Vietnam